PuraPharm Corporation Limited announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was HKD 280.432 million compared to HKD 333.558 million a year ago. Net income was HKD 11.437 million compared to net loss of HKD 45.180 million a year ago. Basic earnings per share was HKD 0.0328 compared to basic loss per share of HKD 0.177 a year ago.